FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claude Preudhomme

Research Profile

Disorders

Physiology

Procedures

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Genes, p53

Co-author Network

Publications

TOP 3
Emna Abdelhamid; Thomas Boyer; Bruno Cassinat; Valerie Coiteux; Martin Figeac; Nathalie Helevaut; Eric Lippert; Olivier Nibourel; Sabine Quief; Aline Renneville; Zohra Soua; Céline Villenet; Claude Preudhomme
Quantification of JAK2V617F mutation by next-generation sequencing technology.
Elise Boudry-Labis; Meyling Cheok; Wendy Cuccuini; Hervé Dombret; Virginie Eclache; Martin Figeac; Nathalie Gachard; Sandrine Geffroy; frederic lepretre; Olivier Nibourel; Christine Perot; Ghislaine Plessis; Claude Preudhomme; Aline Renneville; Catherine Roche-Lestienne; Jean Soulier; Christine Terre; Isabelle Tigaud; Céline Villenet; Nicolas Boissel
Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.
Florent Dumézy; Elise Labis; Caroline Mayeur-Rousse; Olivier Nibourel; Aline Renneville; Claude Preudhomme
Acute myeloid leukemia with translocation t(3;5): new molecular insights.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claude Preudhomme (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Emna Abdelhamid; Thomas Boyer; Bruno Cassinat; Valerie Coiteux; Martin Figeac; Nathalie Helevaut; Eric Lippert; Olivier Nibourel; Sabine Quief; Aline Renneville; Zohra Soua; Céline Villenet; Claude Preudhomme
Quantification of JAK2V617F mutation by next-generation sequencing technology.
American journal of hematology 2013;88(6):536-7.
2013: Elise Boudry-Labis; Meyling Cheok; Wendy Cuccuini; Hervé Dombret; Virginie Eclache; Martin Figeac; Nathalie Gachard; Sandrine Geffroy; frederic lepretre; Olivier Nibourel; Christine Perot; Ghislaine Plessis; Claude Preudhomme; Aline Renneville; Catherine Roche-Lestienne; Jean Soulier; Christine Terre; Isabelle Tigaud; Céline Villenet; Nicolas Boissel
Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.
American journal of hematology 2013;88(4):306-11.
2013: Florent Dumézy; Elise Labis; Caroline Mayeur-Rousse; Olivier Nibourel; Aline Renneville; Claude Preudhomme
Acute myeloid leukemia with translocation t(3;5): new molecular insights.
Haematologica 2013;98(4):e52-4.
2013: Eric Jourdan; Bruno Lioure; Isabelle Luquet; Cécile Pautas; Arnaud Pigneux; Claude Preudhomme; Emmanuel Raffoux; Christian Recher; Aline Renneville; Christine Terré; Xavier Thomas; Norbert Vey; Marie C Béné; Céline Berthon; Odile Blanchet; Nicolas Boissel; Claude-Eric Bulabois; Jean-Michel Cayuela; Sylvie Chevret; Pascale Cornillet; Eric Delabesse; Jacques Delaunay; Hervé Dombret; Philippe Guardiola; Norbert Ifrah
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.
Blood 2013;121(12):2213-23.
2013: Raphaël Itzykson; Olivier Kosmider; Guillaume Meurice; Margot Morabito; Cédric Oréar; Uwe Platzbecker; Claude Preudhomme; Philippe Rameau; Aline Renneville; Lionel Adès; Olivier A Bernard; Céline Berthon; François Delhommeau; Nathalie M Droin; Pierre Fenaux; Michaëla Fontenay; Olivier Gagey; William Vainchenker; Eric Solary
Clonal architecture of chronic myelomonocytic leukemias.
Blood 2013;121(12):2186-98.
2013: Claude Gardin; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Aline Renneville; Christine Terré; Xavier Thomas; Pascal Turlure; Nicolas Boissel; Dominique Bordessoule; Sylvie Castaigne; Karine Celli-Lebras; Sylvie Chevret; Stéphane de Botton; Thierry de Revel; Pierre Fenaux; Nathalie Gachard; Hervé Dombret
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(3):321-7.
2012: edouard CORNET; Florent Dumézy; Nathalie Jouy; Pascale Lepelley; Brigitte Nelken; Nathalie Philippe; Bruno Quesnel; Aline Renneville; Christophe Roumier; Céline Berthon; Claude Preudhomme
Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis.
Leukemia research 2012;36(11):1330-3.
2012: Xavier Thomas; Nicolas Boissel; Jean-Henri Bourhis; Sylvie Castaigne; Youcef Chelghoum; Catherine Cordonnier; Stéphane de Botton; Thierry de Revel; Mohamed Elhamri; Pierre Fenaux; Claude Gardin; Mauricette Michallet; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Oumedaly Reman; Aline Renneville; Gérard Socié; Christine Terré; Hervé Dombret
Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial.
Leukemia research 2012;36(9):1112-8.
2012: Aline Renneville; T de Revel; Christine Terre; Xavier Thomas; Oumedaly Reman; C Berthon; Nicolas Boissel; Dominique Bordessoule; S de Botton; Sylvie Castaigne; Jean-Michel Cayuela; Nathalie Contentin; Hervé Dombret; Pierre Fenaux; Claude Gardin; Sandrine Hayette; N Helevaut; O Nibourel; Cécile Pautas; Claude Preudhomme
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Leukemia 2012;26(6):1247-54.
2012: Csaba Bödör; Jamie Cavenagh; Aurélie Charazac; Pascaline Etancelin; Jude Fitzgibbon; Sameena Iqbal; Karolina Kramarzová; Biju Krishnan; András Matolcsy; Claude Preudhomme; Aline Renneville; Matthew Smith; Michael J Barnett; Carolyn Owen
Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
Haematologica 2012;97(6):890-4.
2012: Sylvie Castaigne; Sylvie Chevret; Nathalie Contentin; Noémie de Gunzburg; Thierry de Revel; Hervé Dombret; Pierre Fenaux; Lauris Gastaud; Estelle Henry; Ollivier Legrand; Jean-Pierre Marolleau; Cécile Pautas; Claude Preudhomme; Emmanuel Raffoux; Oumedaly Reman; Philippe Rousselot; Christine Terré; Xavier Thomas; Pascal Turlure; Ahmad Aljijakli; Jean-Noel Bastie; Dominique Bordessoule
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Lancet 2012;379(9825):1508-16.
2012: Frederik Damm; Stéphane de Botton; Véronique Della Valle; François Dreyfus; Michaëla Fontenay; Véronique Gelsi-Boyer; Agnes Guerci-Bresler; Claire Hidalgo-Curtis; Olivier Kosmider; Michael A Morgan; Thomas Prébet; Claude Preudhomme; Aline Renneville; Aline Schmidt-Tanguy; Laurianne Scourzic; Bohrane Slama; Aspasia Stamatoullas-Bastard; Norbert Vey; Olivier A Bernard; Odile Beyne-Rauzy; Daniel Birnbaum; Nadine Carbuccia; Virginie Chesnais; Lucile Couronné; Nicholas C P Cross
Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.
Blood 2012;119(14):3211-8.
2012: Thomas Cluzeau; Maeva Dufies; Arnaud Jacquel; Jean Michel Karsenti; Frederic Luciano; Nicolas Mounier; Claude Preudhomme; Alexandre Puissant; Sophie Raynaud; Aline Renneville; Guillaume ROBERT; Jill-Patrice Cassuto; Patrick Auberger
BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients.
Oncotarget 2012;3(4):490-501.
2012: S Joha; F-X Mahon; A-L Nugues; Claude Preudhomme; Bruno Quesnel; Catherine Roche-Lestienne; C Berthon; V Dauphin; X Dezitter; D Hétuin; Thierry Idziorek
GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells.
Oncogene 2012;31(11):1419-30.
2012: Emna Abdelhamid; Céline Berthon; Sylvie Castaigne; Claude Gardin; Bérengère Gruson; Nathalie Helevaut; Olivier Nibourel; Claude Preudhomme; Philippe Rousselot; Zohra Soua; Aline Renneville
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.
Leukemia research 2012;36(3):316-23.
2011: Christian Rose; Aline Renneville; Catherine Badens; Agnes Charpentier; Martine Fournier; Charles Herbaux; Olivier Nibourel; Serge Pissard; Claude Preudhomme
Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy.
Leukemia research 2011;35(11):e203-5.
2011: Selim Corm; Thierry Facon; Jean Iwaz; Jean-Baptiste Micol; Franck E Nicolini; Claude Preudhomme; N Bossard; Valérie Coiteux; Laurent Roche; Catherine Roche-Lestienne; Laurent Remontet
Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study.
Blood 2011;118(16):4331-7.
2011: Thorsten Braun; Benoit de Renzis; François Dreyfus; Nathalie M Droin; Pierre Fenaux; Michaëla Fontenay; Claude Gardin; Raphael Itzykson; Bertrand Joly; Ingrid Lafon; Kamel Laribi; Guillaume Meurice; Cédric Oréar; Claude Preudhomme; Christian Recher; Aline Renneville; Bruno Royer; Laurence Sanhes; Eric Solary; Andrea Toma; Anne Vekhoff; Norbert Vey; Lionel Ades; Krimo Bouabdallah
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.
Blood 2011;118(14):3824-31.
2011: Catherine Roche-Lestienne; Philippe Rousselot; Valérie Coiteux; C Frimat; Martine Gardembas; françois guilhot; J Guilhot; N Helevaut; E Labis; Laurence Legros; F-X Mahon; A Marceau; O Nibourel; F Nicolini; Claude Preudhomme
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia.
Leukemia 2011;25(10):1661-4.
2011: Xavier Thomas; Nicolas Boissel; Jean-Henri Bourhis; Sylvie Castaigne; Youcef Chelghoum; Stéphane de Botton; Thierry de Revel; Mohamed Elhamri; Pierre Fenaux; Claude Gardin; Yosr Hicheri; Mauricette Michallet; Cécile Pautas; Claude Preudhomme; Bruno Quesnel; Emmanuel Raffoux; Oumedaly Reman; Aline Renneville; Christine Terré; Hervé Dombret
Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study.
Blood 2011;118(7):1754-62.
2011: R Itzykson; O Kosmider; Véronique Mansat-De Mas; Claude Preudhomme; B Quesnel; S Raynaud; Norbert Vey; L Adès; Odile Beyne-Rauzy; T Cluzeau; François Dreyfus; Pierre Fenaux; Michaëla Fontenay; Véronique Gelsi-Boyer
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
Leukemia 2011;25(7):1147-52.
2011: Samuel Quentin; Wendy Cuccuini; Raphael Ceccaldi; Olivier Nibourel; Corinne Pondarre; Marie-Pierre Pagès; Nadia Vasquez; Catherine Dubois d'Enghien; Jérôme Larghero; Régis Peffault de Latour; Vanderson Rocha; Jean-Hugues Dalle; Pascale Schneider; Mauricette Michallet; Gérard Michel; André Baruchel; François Sigaux; Eliane Gluckman; Thierry Leblanc; Dominique Stoppa-Lyonnet; Claude Preudhomme; Gérard Socié; Jean Soulier
Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
Blood 2011;117(15):e161-70.
2011: Sami Joha; Véronique Dauphin; frederic lepretre; Sélim Corm; Franck E Nicolini; Christophe Roumier; Olivier Nibourel; Nathalie Grardel; Véronique Maguer-Satta; Thierry Idziorek; Martin Figeac; Jean-Luc Laï; Bruno Quesnel; Gabriel Etienne; François Guilhot; Eric Lippert; Claude Preudhomme; Catherine Roche-Lestienne
Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients.
Leukemia research 2011;35(4):448-58.
2011: Nicolas Boissel; Olivier Nibourel; Aline Renneville; Pascal Huchette; Hervé Dombret; Claude Preudhomme
Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.
Blood 2011;117(13):3696-7.
2011: Valérie Capraro; Linda Zane; Delphine Poncet; David Perol; Perrine Galia; Claude Preudhomme; Nathalie Bonnefoy-Berard; Eric Gilson; Xavier Thomas; Mohamed El-Hamri; Youcef Chelghoun; Mauricette Michallet; Eric Wattel; Franck Mortreux; David Sibon
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias.
Experimental hematology 2011;39(2):195-202.e2.
2011: Nathalie Itzhar; Philippe Dessen; Saloua Toujani; Nathalie Auger; Claude Preudhomme; Catherine Richon; Vladimir Lazar; Véronique Saada; Anelyse Bennaceur; Jean-Henri Bourhis; Stéphane de Botton; Alain Bernheim
Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.
PloS one 2011;6(2):e16623.
2010: Claude Preudhomme; Joëlle Guilhot; Franck E Nicolini; Agnès Guerci-Bresler; Françoise Rigal-Huguet; Frédéric Maloisel; Valérie Coiteux; Martine Gardembas; Christian Berthou; Anne Vekhoff; Delphine Rea; Eric Jourdan; Christian Allard; Alain Delmer; Philippe Rousselot; Laurence Legros; Marc Berger; Selim Corm; Gabriel Etienne; Catherine Roche-Lestienne; Virginie Eclache; François-Xavier Mahon; François Guilhot
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.
The New England journal of medicine 2010;363(26):2511-21.
2010: John A Pulikkan; Philomina S Peramangalam; Viola Dengler; Phoenix Anh-Dung Ho; Claude Preudhomme; Soheil Meshinchi; Maximilian Christopeit; Oliver Nibourel; Carsten Müller-Tidow; Stefan K Bohlander; Daniel G Tenen; Gerhard Behre
C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
Blood 2010;116(25):5638-49.
2010: Benoîte Pérez; Olivier Kosmider; Bruno Cassinat; Aline Renneville; Julie Lachenaud; Sophie Kaltenbach; Yves Bertrand; André Baruchel; Christine Chomienne; Michaela Fontenay; Claude Preudhomme; Hélène Cavé
Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
British journal of haematology 2010;151(5):460-8.
2010: Olivier Nibourel; Olivier Kosmider; Meyling Cheok; Nicolas Boissel; Aline Renneville; Noël Philippe; Hervé Dombret; François Dreyfus; Bruno Quesnel; Sandrine Geffroy; Samuel Quentin; Catherine Roche-Lestienne; Jean-Michel Cayuela; Christophe Roumier; Pierre Fenaux; William Vainchenker; Olivier A Bernard; Jean Soulier; Michaëla Fontenay; Claude Preudhomme
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.
Blood 2010;116(7):1132-5.
2010: Nicolas Boissel; Olivier Nibourel; Aline Renneville; Claude Gardin; Oumedaly Reman; Nathalie Contentin; Dominique Bordessoule; Cécile Pautas; Thierry de Revel; Bruno Quesnel; Pascal Huchette; Noël Philippe; Sandrine Geffroy; Christine Terre; Xavier Thomas; Sylvie Castaigne; Hervé Dombret; Claude Preudhomme
Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(23):3717-23.
2010: Xavier Thomas; Emmanuel Raffoux; Aline Renneville; Cecile Pautas; Stephane de Botton; Christine Terre; Claude Gardin; Sandrine Hayette; Claude Preudhomme; Hervé Dombret
Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF study.
Cancer 2010;116(7):1725-32.
2010: Cecile Pautas; Fatiha Merabet; Xavier Thomas; Emmanuel Raffoux; Claude Gardin; Selim Corm; Jean-Henri Bourhis; Oumedaly Reman; Pascal Turlure; Nathalie Contentin; Thierry de Revel; Philippe Rousselot; Claude Preudhomme; Dominique Bordessoule; Pierre Fenaux; Christine Terré; Mauricette Michallet; Hervé Dombret; Sylvie Chevret; Sylvie Castaigne
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):808-14.
2010: H Lapillonne; L Llopis; A Auvrignon; Aline Renneville; Myriam Labopin; F Mazingue; C Perot; Jean-Luc Lai; Noël Philippe; Paola Ballerini; V Zurawski; Mircéa Adam; Luc Douay; Guy Leverger; J Landman-Parker; Claude Preudhomme
Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia.
Leukemia 2010;24(1):205-9.
2010: Racha Alkhatib; Sami Joha; Meyling Cheok; Vincent Roumy; Thierry Idziorek; Claude Preudhomme; Bruno Quesnel; Sevser Sahpaz; François Bailleul; Thierry Hennebelle
Activity of ladanein on leukemia cell lines and its occurrence in Marrubium vulgare.
Planta medica 2010;76(1):86-7.
2009: Franck E Nicolini; Michael J Mauro; Giovanni Martinelli; Dong-Wook Kim; Simona Soverini; Martin C Müller; Andreas Hochhaus; Jorge Cortes; Charles Chuah; Inge H Dufva; Jane F Apperley; Fumiharu Yagasaki; Jay D Pearson; Senaka Peter; Cesar Sanz-Rodriguez; Claude Preudhomme; Francis Giles; John M Goldman; Wei Zhou
Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation.
Blood 2009;114(26):5271-8.
2009: Jean Baptiste Micol; Nicolas Boissel; Aline Renneville; Sylvie Castaigne; Claude Gardin; Claude Preudhomme; Hervé Dombret
The role of cytogenetic abnormalities in acute myeloid leukemia with NPM1 mutations and no FLT3 internal tandem duplication.
Blood 2009;114(20):4601-2; author reply 4602-3.
2009: Daniela Cilloni; Aline Renneville; fabienne hermitte; Robert K Hills; Sarah Daly; Jelena V Jovanovic; Enrico Gottardi; Milena Fava; Susanne Schnittger; Tamara Weiss; Barbara Izzo; Josep Nomdedeu; Adrian van der Heijden; Bert A van der Reijden; Joop H Jansen; Vincent H J van der Velden; Hans Ommen; Claude Preudhomme; Giuseppe Saglio; David Grimwade
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5195-201.
2009: Olivier Kosmider; Véronique Gelsi-Boyer; Meyling Cheok; Sophie Grabar; Véronique Della Valle; Françoise Picard; Franck Viguié; Bruno Quesnel; Odile Beyne-Rauzy; Eric Solary; Norbert Vey; Mathilde Hunault-Berger; Pierre Fenaux; Véronique Mansat-De Mas; Eric Delabesse; Philippe Guardiola; Catherine Lacombe; William Vainchenker; Claude Preudhomme; François Dreyfus; Olivier A Bernard; Daniel Birnbaum; Michaëla Fontenay
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).
Blood 2009;114(15):3285-91.
2009: Thomas Clozel; Aline Renneville; Marion Venot; Claude Gardin; Charikleia Kelaidi; Geneviève Leroux; Virginie Eclache; Claude Preudhomme; Pierre Fenaux; Lionel Adès
Slow relapse in acute myeloid leukemia with inv(16) or t(16;16).
Haematologica 2009;94(10):1466-8.
2009: Aline Renneville; Nicolas Boissel; Virginie Zurawski; Laura Llopis; Valéria Biggio; Olivier Nibourel; Noël Philippe; Xavier Thomas; Hervé Dombret; Claude Preudhomme
Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Cancer 2009;115(16):3719-27.
2009: Claude Preudhomme; Aline Renneville; Violaine Bourdon; Noël Philippe; Catherine Roche-Lestienne; Nicolas Boissel; Nathalie Dhedin; Jean-Marie André; Pascale Cornillet-Lefebvre; André Baruchel; Marie-Joelle Mozziconacci; Hagay Sobol
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.
Blood 2009;113(22):5583-7.
2009: Aline Renneville; Nicolas Boissel; Nathalie Gachard; Dina Naguib; Christian Bastard; Stéphane de Botton; Olivier Nibourel; Cécile Pautas; Oumedaly Reman; Xavier Thomas; Claude Gardin; Christine Terré; Sylvie Castaigne; Claude Preudhomme; Hervé Dombret
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication.
Blood 2009;113(21):5090-3.
2009: Hervé Dombret; Claude Preudhomme; Nicolas Boissel
Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?
Current opinion in hematology 2009;16(2):92-7.
2009: Louis Terriou; Raouf Ben-Abdelali; Christophe Roumier; Ludovic Lhermitte; John De Vos; Pascale Cornillet; Olivier Nibourel; Kheira Beldjord; Hervé Dombret; Guy Leverger; Vahid Asnafi; Claude Preudhomme; Elizabeth Macintyre
C/EBPA methylation is common in T-ALL but not in M0 AML.
Blood 2009;113(8):1864-6; author reply 1866.
2009: Christoph Walz; J Score; J Mix; D Cilloni; C Roche-Lestienne; R-F Yeh; J L Wiemels; E Ottaviani; Philipp Erben; Andreas Hochhaus; M Baccarani; D Grimwade; Claude Preudhomme; J Apperley; giovanni martinelli; Giuseppe Saglio; Nicholas C P Cross; Andreas Reiter
The molecular anatomy of the FIP1L1-PDGFRA fusion gene.
Leukemia 2009;23(2):271-8.
2008: Racha Alkhatib; Thierry Hennebelle; Sami Joha; Thierry Idziorek; Claude Preudhomme; Bruno Quesnel; Sevser Sahpaz; François Bailleul
Activity of elaeochytrin A from Ferula elaeochytris on leukemia cell lines.
Phytochemistry 2008;69(17):2979-83.
2008: Lauréline Deluche; Sami Joha; Sélim Corm; Agnès Daudignon; Sandrine Geffroy; Sabine Quief; Céline Villenet; Jean-Pierre Kerckaert; Jean-Luc Laï; Claude Preudhomme; Catherine Roche-Lestienne
Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
Genes, chromosomes & cancer 2008;47(12):1110-7.
2008: Steven Richebourg; Olivier Theisen; Isabelle Plantier; Anne Parry; Valérie Soenen-Cornu; Pascale Lepelley; Claude Preudhomme; Aline Renneville; Jean-Luc Laï; Catherine Roche-Lestienne
Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia.
Genes, chromosomes & cancer 2008;47(10):915-8.
2008: Catherine Roche-Lestienne; Lauréline Deluche; Sélim Corm; Isabelle Tigaud; Sami Joha; Nathalie Philippe; Sandrine Geffroy; Jean-Luc Laï; Franck-Emmanuel Nicolini; Claude Preudhomme
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.
Blood 2008;111(7):3735-41.
2007: S Burgstaller; Sebastian Kreil; Katherine Waghorn; Georgia Metzgeroth; Claude Preudhomme; Katerina Zoi; H White; Daniela Cilloni; Christine Zoi; Finella Brito-Babapulle; Christoph Walz; Andreas Reiter; Nicholas C P Cross
The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus.
Leukemia 2007;21(12):2428-32.
2007: Selim Corm; Aline Renneville; E Rad-Quesnel; Nathalie Grardel; Claude Preudhomme; Bruno Quesnel
Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation.
Leukemia 2007;21(11):2376-7.
2007: Franck E Nicolini; Sandrine Hayette; Selim Corm; Emmanuel Bachy; Dominique Bories; Micheline Tulliez; françois guilhot; Laurence Legros; Frédéric Maloisel; Jean-Jacques Kiladjian; François-Xavier Mahon; Quoc-Hung Lê; Mauricette Michallet; Catherine Roche-Lestienne; Claude Preudhomme
Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation.
Haematologica 2007;92(9):1238-41.
2007: Claude Gardin; Pascal Turlure; Thierry Fagot; Xavier Thomas; Christine Terre; Nathalie Contentin; Emmanuel Raffoux; Stéphane de Botton; Cécile Pautas; Oumedaly Reman; Jean-Henri Bourhis; Pierre Fenaux; Sylvie Castaigne; Mauricette Michallet; Claude Preudhomme; Thierry de Revel; Dominique Bordessoule; Hervé Dombret
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.
Blood 2007;109(12):5129-35.
2007: Jelena V Jovanovic; Joannah Score; Katherine Waghorn; Daniela Cilloni; Enrico Gottardi; Georgia Metzgeroth; Philipp Erben; Helena Popp; Christoph Walz; Andreas Hochhaus; Catherine Roche-Lestienne; Claude Preudhomme; Ellen Solomon; Jane Apperley; Michela Rondoni; Emanuela Ottaviani; giovanni martinelli; Finella Brito-Babapulle; Giuseppe Saglio; Rüdiger Hehlmann; Nicholas C P Cross; Andreas Reiter; David Grimwade
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.
Blood 2007;109(11):4635-40.
2007: Xavier Thomas; Emmanuel Raffoux; S de Botton; Cécile Pautas; Philippe Arnaud; Thierry de Revel; Oumedaly Reman; Christine Terré; B Corront; Claude Gardin; Quoc-Hung Le; Bruno Quesnel; Catherine Cordonnier; Jean-Henri Bourhis; Mohamed Elhamri; Pierre Fenaux; Claude Preudhomme; Mauricette Michallet; Sylvie Castaigne; Hervé Dombret
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.
Leukemia 2007;21(3):453-61.
2007: Franck E Nicolini; Selim Corm; Quoc-Hung Lê; Catherine Roche-Lestienne; Claude Preudhomme
The prognosis impact of BCR-ABL P-loop mutations: worse or not worse?
Leukemia 2007;21(2):193-4.
2006: C Picard; Sandrine Hayette; Chrystèle Bilhou-Nabera; Jean-Michel Cayuela; Eric Delabesse; N Frenoy; Claude Preudhomme; M Dupont; Christian Bastard; Dominique Bories; Jean-Luc Vaerman; Frédéric Davi; Nicole Dastugue; Sophie Raynaud; Marina Lafage; Frederic Deschaseaux; Thierry Fest; M P Gaub; Véronique Lhéritier; Xavier Thomas; Christiane Charrin; Claude Boucheix; Hervé Dombret; Elizabeth Macintyre; Denis Fière; Jean Gabert
Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience.
Leukemia 2006;20(12):2178-81.
2006: Aline Renneville; Bruno Quesnel; A Charpentier; Louis Terriou; A Crinquette; Jean-Luc Laï; C Cossement; P Lionne-Huyghe; C Rose; Francis Bauters; Claude Preudhomme
High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Leukemia 2006;20(11):2067-70.
2006: Franck E Nicolini; Selim Corm; Quoc-Hung Lê; Nathalie Sorel; Sandrine Hayette; Dominique Bories; Thibaut Leguay; L Roy; Stéphane Giraudier; Micheline Tulliez; Thierry Facon; François-Xavier Mahon; Jean-Michel Cayuela; Philippe Rousselot; Mauricette Michallet; Claude Preudhomme; françois guilhot; Catherine Roche-Lestienne
Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP).
Leukemia 2006;20(6):1061-6.
2006: Nicolas Boissel; Hugues Leroy; Benoît Brethon; Noël Philippe; Stéphane de Botton; Anne Auvrignon; Emmanuel Raffoux; Thierry Leblanc; Xavier Thomas; Olivier Hermine; Bruno Quesnel; André Baruchel; Guy Leverger; Hervé Dombret; Claude Preudhomme
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).
Leukemia 2006;20(6):965-70.
2006: Hélène Lapillonne; Aline Renneville; Anne Auvrignon; Cyril Flamant; Annick Blaise; Christine Perot; Jean-Luc Lai; Paola Ballerini; Françoise Mazingue; Sylvie Fasola; Axelle Dehée; Françoise Bellman; Mircéa Adam; Myriam Labopin; Luc Douay; Guy Leverger; Claude Preudhomme; Judith Landman-Parker
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1507-15.
2006: Christophe Roumier; S Lejeune-Dumoulin; Aline Renneville; A S Goethgeluck; Noël Philippe; Pierre Fenaux; Claude Preudhomme
Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.
Leukemia 2006;20(3):433-6.
2006: Marie Colombat; Marie-Pierre Fort; Claudine Chollet; Gérald Marit; Catherine Roche; Claude Preudhomme; Josy Reiffers; Vincent Praloran; François-Xavier Mahon
Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment.
Haematologica 2006;91(2):162-8.
2006: Daniel J Pearce; David C Taussig; Kazem Zibara; Lan-Lan Smith; Christopher M Ridler; Claude Preudhomme; Bryan D Young; Ama Z S Rohatiner; T Andrew Lister; Dominique Bonnet
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.
Blood 2006;107(3):1166-73.
2005: Nicolas Boissel; Aline Renneville; Valeria Biggio; Noël Philippe; Xavier Thomas; Jean-Michel Cayuela; Christine Terre; Isabelle Tigaud; Sylvie Castaigne; Emmanuel Raffoux; Stéphane de Botton; Pierre Fenaux; Hervé Dombret; Claude Preudhomme
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.
Blood 2005;106(10):3618-20.
2005: Selim Corm; Valeria Biggio; Catherine Roche-Lestienne; Jean-Luc Laï; Ibrahim Yakoub-Agha; Noël Philippe; Franck E Nicolini; Thierry Facon; Claude Preudhomme
Coexistence of AML1/RUNX1 and BCR-ABL point mutations in an imatinib-resistant form of CML.
Leukemia 2005;19(11):1991-2.
2005: Emmanuel Gyan; M Frew; D Bowen; C Beldjord; Claude Preudhomme; C Lacombe; P Mayeux; François Dreyfus; Françoise Porteu; Michaëla Fontenay
Mutation in RAP1 is a rare event in myelodysplastic syndromes.
Leukemia 2005;19(9):1678-80.
2005: Frédéric Millot; Françoise Brizard; Nathalie Sorel; Claude Preudhomme; Marie Cividin; françois guilhot; André Brizard
Therapy-related acute lymphoblastic leukemia with MLL rearrangement following treatment of Burkitt's leukemia.
Leukemia & lymphoma 2005;46(6):925-7.
2005: Leroy Hugues; Hélène Cavé; Nathalie Philippe; Sabrina Pereira; Pierre Fenaux; Claude Preudhomme
Mutations of PTPN11 are rare in adult myeloid malignancies.
Haematologica 2005;90(6):853-4.
2005: Catherine Roche-Lestienne; S Lepers; Valérie Soenen-Cornu; Jean-Emmanuel Kahn; Jean-Luc Laï; E Hachulla; F Drupt; A-L Demarty; Anne Roumier; Martine Gardembas; M Dib; Noël Philippe; Nathalie Cambier; S Barete; C Libersa; Olivier Bletry; Pierre-Yves Hatron; Bruno Quesnel; Christian Rose; K Maloum; Odile Blanchet; Pierre Fenaux; Lionel Prin; Claude Preudhomme
Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.
Leukemia 2005;19(5):792-8.
2005: Valérie Soenen-Cornu; Cristina Tourino; Marie-Laure Bonnet; Martine Guillier; Stéphane Flamant; Rami Kotb; Alain BERNHEIM; Jean-Henri Bourhis; Claude Preudhomme; Pierre Fenaux; Ali G Turhan
Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.
Oncogene 2005;24(15):2441-8.
2005: Adrienne de Labarthe; Cécile Pautas; Xavier Thomas; Stéphane de Botton; Dominique Bordessoule; Hervé Tilly; Thierry de Revel; Christian Bastard; Claude Preudhomme; Mauricette Michallet; Pierre Fenaux; Jean-Noël Bastie; Gérard Socié; Catherine Cordonnier; Hervé Dombret
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
Bone marrow transplantation 2005;35(8):767-73.
2005: Emmanuelle Barouk-Simonet; Valérie Soenen-Cornu; Christophe Roumier; Alain Cosson; Jean-Luc Laï; Pierre Fenaux; Claude Preudhomme
Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases.
Cancer genetics and cytogenetics 2005;157(2):118-26.
2005: Hugues Leroy; Stéphane de Botton; Nathalie Grardel-Duflos; Stéphane Darre; Xavier Leleu; Christophe Roumier; Franck Morschhauser; Jean-Luc Lai; Francis Bauters; Pierre Fenaux; Claude Preudhomme
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).
Leukemia 2005;19(3):367-72.
2005: Hugues Leroy; Christophe Roumier; Pauline Huyghe; Valeria Biggio; Pierre Fenaux; Claude Preudhomme
CEBPA point mutations in hematological malignancies.
Leukemia 2005;19(3):329-34.
2005: Catherine Roche-Lestienne; Stéphane Darré; Jean-Luc Laï; Thierry Facon; Joëlle Guilhot; Claude Preudhomme
Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinib.
Haematologica 2005;90(1):131-3.
2004: Catherine Roche-Lestienne; François-Xavier Mahon; Claude Preudhomme
[Origin of resistance to Imatinib mesylate: lessons learned from this experience].
Médecine sciences : M/S 2004;20(12):1125-30.
2004: Sylvie Castaigne; Sylvie Chevret; Eric Archimbaud; Pierre Fenaux; Dominique Bordessoule; Hervé Tilly; Thierry de Revel; Marc Simon; Brigitte Dupriez; Michel Renoux; Maud Janvier; Jean-Michel Micléa; Xavier Thomas; Christian Bastard; Claude Preudhomme; Francis Bauters; Laurent Degos; Hervé Dombret
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.
Blood 2004;104(8):2467-74.
2004: Lucie Lafay-Cousin; Valérie Soenen; Françoise Mazingue; Claude Preudhomme; Jean-Luc Laï; Joris Andrieux
Chromosomal insertion involving MLL in childhood acute myeloblastic leukemia (M4).
Cancer genetics and cytogenetics 2004;150(2):153-5.
2004: Constantina Sambani; Roberta La Starza; Christophe Roumier; Barbara Crescenzi; Chryssa Stavropoulou; Olga Katsarou; Anastasia Karafoulidou; Jean Hugues Dhalle; Jean-Luc Lai; Claude Preudhomme; Massimo F Martelli; Cristina Mecucci
Partial duplication of the MLL oncogene in patients with aggressive acute myeloid leukemia.
Haematologica 2004;89(4):403-7.
2004: Stéphane Depil; Pascale Lepelley; Valérie Soenen; Claude Preudhomme; Jean-Luc Lai; F Broly; Bruno Quesnel
A case of refractory anemia with 17p- syndrome following azathioprine treatment for heart transplantation.
Leukemia 2004;18(4):878.
2004: Christian Rose; S Dupire; Catherine Roche-Lestienne; Nathalie Grardel; E Bourgeois; Nathalie Cambier; Claude Preudhomme
Sustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome in relapse after allograft.
Leukemia 2004;18(2):354-5.
2004: Hélène Cavé; Stefan Suciu; Claude Preudhomme; Bruce Poppe; Alain Robert; Anne Uyttebroeck; Michèle Malet; Patrick Boutard; Yves Benoit; Laurent Mauvieux; Patrick Lutz; Françoise Méchinaud; Nathalie Grardel; Françoise Mazingue; Madeleine Dupont; Geneviève Margueritte; Marie-Pierre Pages; Yves Bertrand; Emmanuel Plouvier; Ghislaine Brunie; Christian Bastard; Dominique Plantaz; Isabel Vande Velde; Anne Hagemeijer; Frank Speleman; michel lessard; Jacques Otten; Etienne Vilmer; Nicole Dastugue
Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.
Blood 2004;103(2):442-50.
2003: Jean-Hugues Dalle; Pierre Leblond; A Decouvelaere; Ibrahim Yakoub-Agha; Claude Preudhomme; Brigitte Nelken; Françoise Mazingue
Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL.
Leukemia 2003;17(10):2056-7.
2003: Catherine Roche-Lestienne; Jean-Luc Laï; Stéphane Darré; Thierry Facon; Claude Preudhomme
A mutation conferring resistance to imatinib at the time of diagnosis of chronic myelogenous leukemia.
The New England journal of medicine 2003;348(22):2265-6.
2003: Catherine Roche-Lestienne; Claude Preudhomme
Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment.
Seminars in hematology 2003;40(2 Suppl 2):80-2.
2003: Christophe Roumier; Virginie Eclache; Michèle Imbert; Frédéric Davi; Elizabeth Macintyre; Richard Garand; Pascaline Talmant; Pascale Lepelley; Jean-Luc Lai; Olivier Casasnovas; Marc Maynadie; Francine Mugneret; Chrystele Bilhou-Naberra; Françoise Valensi; Isabelle Radford; Marie-Joëlle Mozziconacci; Christine Arnoulet; Eliane Duchayne; Nicole Dastugue; Pascale Cornillet; Sylvie Daliphard; Francine Garnache; Najiba Boudjerra; Hélène Jouault; Odile Fenneteau; Béatrice Pedron; Roland Berger; Georges Flandrin; Pierre Fenaux; Claude Preudhomme
M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).
Blood 2003;101(4):1277-83.
2003: Christophe Roumier; Pierre Fenaux; Marina Lafage; Michèle Imbert; Virginie Eclache; Claude Preudhomme
New mechanisms of AML1 gene alteration in hematological malignancies.
Leukemia 2003;17(1):9-16.
2002: Charlotte Lamandin; Christophe Sagot; Christophe Roumier; Pascale Lepelley; Stéphane de Botton; Alain Cosson; Pierre Fenaux; Claude Preudhomme
Are PU.1 mutations frequent genetic events in acute myeloid leukemia (AML)?
Blood 2002;100(13):4680-1.
2002: Claude Preudhomme; Christophe Sagot; Nicolas Boissel; Jean-Michel Cayuela; Isabelle Tigaud; Stéphane de Botton; Xavier Thomas; Emmanuel Raffoux; Charlotte Lamandin; Sylvie Castaigne; Pierre Fenaux; Hervé Dombret
Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).
Blood 2002;100(8):2717-23.
2002: Nicolas Boissel; Jean-Michel Cayuela; Claude Preudhomme; Xavier Thomas; Nathalie Grardel; Xavier Fund; Isabelle Tigaud; Emmanuel Raffoux; Philippe Rousselot; François Sigaux; Laurent Degos; Sylvie Castaigne; Pierre Fenaux; Hervé Dombret
Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy.
Leukemia 2002;16(9):1699-704.
2002: Batia Stark; Marta Jeison; Claude Preudhomme; Pierre Fenaux; Shifra Ash; Yifat Korek; Jerry Stein; Rina Zaizov; Isaac Yaniv
Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins.
British journal of haematology 2002;118(4):1082-6.
2002: Catherine Roche-Lestienne; Valérie Soenen-Cornu; Nathalie Grardel-Duflos; Jean-Luc Laï; Noël Philippe; Thierry Facon; Pierre Fenaux; Claude Preudhomme
Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.
Blood 2002;100(3):1014-8.
2002: Emmanuelle Barouk-Simonet; Joris Andrieux; Marie-Christine Copin; Nathalie Grardel-Duflos; Pauline Huyghe; Jean-Hugues Patte; Claude Preudhomme; Bruno Quesnel; Jean-Luc Laï
TPA stimulation culture for improved detection of t(11;14)(q13;q32) in mantle cell lymphoma.
Annales de génétique 2002;45(3):165-8.
2002: Dominique Penther; Claude Preudhomme; Pascaline Talmant; Christophe Roumier; Alban Godon; Françoise Méchinaud; Noël Milpied; Régis Bataille; Hervé Avet-Loiseau
Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation.
Leukemia 2002;16(6):1131-4.
2002: Hugues Leroy; Christophe Roumier; Nathalie Grardel-Duflos; Elizabeth Macintyre; Pascale Lepelley; Pierre Fenaux; Claude Preudhomme
Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.
Blood 2002;99(10):3848-50.
2002: Christophe Zawadzki; Claude Preudhomme; Valérie Gavériaux; Philippe Amouyel; Brigitte Jude
The Arg200Trp mutation in the human tissue factor gene.
Thrombosis and haemostasis 2002;87(3):540-1.
2002: I Lobe; Stéphane Darre; P Gosset; M Mahieu; Jean-Luc Lai; Claude Preudhomme; Nathalie Cambier; C Rose
[Serous non-Hodgkin's lymphoma in immunocompetent patient].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2002;23(2):209-10.
2002: Nathalie Grardel; Christophe Roumier; Valérie Soenen; Jean-Luc Lai; Isabelle Plantier; C Gheveart; Alain Cosson; Pierre Fenaux; Claude Preudhomme
Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFbeta-MYH11 transcript: report of two new cases.
Leukemia 2002;16(1):150-1.
2001: Valérie Soenen; Pascale Lepelley; Emmanuel Gyan; Claude Preudhomme; Jean-Luc Lai; Francis Bauters; Pierre Fenaux; Bruno Quesnel
Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype.
Leukemia 2001;15(7):1054-9.
2001: Catherine Nisse; Jean-Marie Haguenoer; B Grandbastien; Claude Preudhomme; B Fontaine; J M Brillet; R Lejeune; Pierre Fenaux
Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France.
British journal of haematology 2001;112(4):927-35.
2000: Stéphane de Botton; Sylvie Chevret; M Sanz; Hervé Dombret; Xavier Thomas; Agnès Guerci; Martin Fey; C Rayon; Francoise Huguet; Jean-Jacques Sotto; Claude Gardin; Pascale Cony-Makhoul; Philippe Travade; Eric Solary; Nathalie Fegueux; Dominique Bordessoule; Jesús San Miguel; H Link; Bernard Desablens; Aspasia Stamatoullas; Eric DECONINCK; K Geiser; Urs Hess; Frédéric Maloisel; Sylvie Castaigne; Claude Preudhomme; Christine Chomienne; Laurent Degos; Pierre Fenaux
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
British journal of haematology 2000;111(3):801-6.
2000: Claude Preudhomme; D Warot-Loze; Christophe Roumier; Nathalie Grardel-Duflos; Richard Garand; Jean-Luc Lai; Nicole Dastugue; Elizabeth Macintyre; Claude Denis; Francis Bauters; Jean-Pierre Kerckaert; Alain Cosson; Pierre Fenaux
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Blood 2000;96(8):2862-9.
2000: S Poulain; Pascale Lepelley; Claude Preudhomme; Nathalie Cambier; J Cornillon; Eric Wattel; Alain Cosson; Pierre Fenaux
Expression of the multidrug resistance-associated protein in myelodysplastic syndromes.
British journal of haematology 2000;110(3):591-8.
2000: Rodolphe Vereecque; G Buffenoir; Claude Preudhomme; Dominique Hetuin; Francis Bauters; Pierre Fenaux; Bruno Quesnel
Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease.
Gene therapy 2000;7(15):1312-6.
2000: Nathalie Cambier; Valérie Soenen-Cornu; Jean-Luc Laï; Alain Cosson; Pierre Fenaux; Claude Preudhomme
Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases.
Haematologica 2000;85(6):664-5.
2000: Max Chaffanet; L Gressin; Claude Preudhomme; Valérie Soenen-Cornu; Daniel Birnbaum; Marie-Josèphe Pébusque
MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).
Genes, chromosomes & cancer 2000;28(2):138-44.
2000: Claude Preudhomme; Christophe Roumier; M P Hildebrand; E Dallery-Prudhomme; Danièle Lantoine; Jean-Luc Laï; Agnès Daudignon; C Adenis; Francis Bauters; Pierre Fenaux; Jean-Pierre Kerckaert; Sylvie Galiègue-Zouitina
Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma.
Oncogene 2000;19(16):2023-32.
2000: Franck Morschhauser; Jean-Michel Cayuela; S Martini; André Baruchel; Philippe Rousselot; Gérard Socié; P Berthou; Jean-Pierre Jouet; N Straetmans; François Sigaux; Pierre Fenaux; Claude Preudhomme
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):788-94.
2000: Christophe Roumier; Sylvie Galiègue-Zouitina; Christian Bastard; Valérie Soenen; Jean-Luc Laï; Claude Denis; Gérard Buchonnet; Jean-Pierre Kerckaert; Alain Cosson; Pierre Fenaux; Claude Preudhomme
FISH analysis with a YAC probe improves detection of LAZ3/BCL6 rearrangement in non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(2):117-25.
1999: Christophe Roumier; Agnès Daudignon; Valérie Soenen; Brigitte Dupriez; Marc Wetterwald; Jean-Luc Lai; Alain Cosson; Pierre Fenaux; Claude Preudhomme
p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Haematologica 1999;84(12):1075-80.
1999: Pierre Fenaux; C Chastang; Sylvie Chevret; M Sanz; Hervé Dombret; Eric Archimbaud; Martin Fey; C Rayon; Francoise Huguet; Jean-Jacques Sotto; Claude Gardin; P C Makhoul; Philippe Travade; Eric Solary; Nathalie Fegueux; Dominique Bordessoule; JS Miguel; H Link; Bernard Desablens; Aspasia Stamatoullas; Eric DECONINCK; Frédéric Maloisel; Sylvie Castaigne; Claude Preudhomme; Laurent Degos
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.
Blood 1999;94(4):1192-200.
1999: Claude Preudhomme; Françoise Révillion; A Merlat; Louis Hornez; Christophe Roumier; N Duflos-Grardel; J P Jouet; Alain Cosson; Jean-Philippe Peyrat; Pierre Fenaux
Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay.
Leukemia 1999;13(6):957-64.
1999: Claude Preudhomme; L Chams-Eddine; Christophe Roumier; N Duflos-Grardel; Claude Denis; Alain Cosson; Pierre Fenaux
Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
Leukemia 1999;13(5):818-23.
1999: A Merlat; Jean-Luc Lai; Y Sterkers; Jean-Loup Demory; Francis Bauters; Claude Preudhomme; Pierre Fenaux
Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.
Leukemia 1999;13(2):250-7.
1998: Christophe Zawadzki; V Gaveriaux; Nathalie Trillot; Anne Bauters; A Watel; Martine Alhenc-Gelas; Claude Preudhomme; Brigitte Jude
Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: two cases in a French family.
Thrombosis and haemostasis 1998;80(6):1027-8.
1998: Pascale Lepelley; S Poulain; Nathalie Grardel; Claude Preudhomme; Alain Cosson; Pierre Fenaux
Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.
Leukemia & lymphoma 1998;29(5-6):547-51.
1998: Bruno Quesnel; Gaëlle Guillerm; Rodolphe Vereecque; Eric Wattel; Claude Preudhomme; Francis Bauters; M Vanrumbeke; Pierre Fenaux
Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression.
Blood 1998;91(8):2985-90.
1998: T Vallespí; Michèle Imbert; C Mecucci; Claude Preudhomme; Pierre Fenaux
Diagnosis, classification, and cytogenetics of myelodysplastic syndromes.
Haematologica 1998;83(3):258-75.
1998: Valérie Soenen; Claude Preudhomme; Christophe Roumier; Jean-Luc Laï; Pascale Lepelley; T Facon; D Pagniez; Pierre Fenaux
Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells.
Leukemia 1998;12(2):238-41.
1998: Valérie Soenen; Claude Preudhomme; Christophe Roumier; Agnès Daudignon; Jean-Luc Laï; Pierre Fenaux
17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ.
Blood 1998;91(3):1008-15.
1998: Y Sterkers; Claude Preudhomme; Jean-Luc Laï; Jean-Loup Demory; Marie Thérèse Caulier; Eric Wattel; Dominique Bordessoule; Francis Bauters; Pierre Fenaux
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.
Blood 1998;91(2):616-22.
1998: Claude Preudhomme; M Vanrumbeke; L Detourmignies; T Facon; Pascale Lepelley; thierry soussi; Pierre Fenaux
Very low incidence of p53 antibodies in adult non-Hodgkin's lymphoma and multiple myeloma.
British journal of haematology 1998;100(1):184-6.
1997: Eric Wattel; Stéphane de Botton; J Luc Laï; Claude Preudhomme; Pascale Lepelley; Francis Bauters; Pierre Fenaux
Long-term follow-up of de novo myelodysplastic syndromes treated with intensive chemotherapy: incidence of long-term survivors and outcome of partial responders.
British journal of haematology 1997;98(4):983-91.
1997: Claude Preudhomme; Catherine Nisse; M Hebbar; M Vanrumbeke; A Brizard; Jean-Luc Lai; Pierre Fenaux
Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens.
Leukemia 1997;11(9):1580-2.
1997: Hélène Cavé; V Cacheux; Sophie Raynaud; Ghislaine Brunie; Marleen Bakkus; P Cochaux; Claude Preudhomme; J L Laï; Etienne Vilmer; Bernard Grandchamp
ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia.
Leukemia 1997;11(9):1459-64.
1997: E Dallery-Prudhomme; Christophe Roumier; Claude Denis; Claude Preudhomme; Jean-Pierre Kerckaert; S Galiegue-Zouitina
Genomic structure and assignment of the RhoH/TTF small GTPase gene (ARHH) to 4p13 by in situ hybridization.
Genomics 1997;43(1):89-94.
1997: Marc Zandecki; F Bernardi; Franck Genevieve; Jean-Luc Laï; Claude Preudhomme; M Flactif; Alain Cosson; Francis Bauters; Thierry Facon
Involvement of peripheral blood cells in multiple myeloma: chromosome changes are the rule within circulating plasma cells but not within B lymphocytes.
Leukemia 1997;11(7):1034-9.
1997: Claude Preudhomme; N Henic; B Cazin; Jean-Luc Lai; M F Bertheas; M Vanrumbeke; F Lemoine; J P Jouet; E Deconninck; B Nelken; Alain Cosson; Pierre Fenaux
Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL).
Leukemia 1997;11(2):294-8.
1996: Pascale Lepelley; L Campergue; Nathalie Grardel; Claude Preudhomme; Alain Cosson; Pierre Fenaux
Is apoptosis a massive process in myelodysplastic syndromes?
British journal of haematology 1996;95(2):368-71.
1996: Bruno Quesnel; Claude Preudhomme; Pascale Lepelley; D Hetuin; M Vanrumbeke; Francis Bauters; T Velu; Pierre Fenaux
Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation.
British journal of haematology 1996;95(2):291-8.
1996: Bruno Quesnel; Claude Preudhomme; P Fenaux
p16ink4a gene and hematological malignancies.
Leukemia & lymphoma 1996;22(1-2):11-24.
1996: Valérie Soenen; Max Chaffanet; Claude Preudhomme; A Dib; Jean-Luc Lai; J A Fletcher; D Birnbaurn; Marie-Josèphe Pébusque
Identification of a YAC spanning the translocation breakpoint t(8;22) associated with acute monocytic leukemia.
Genes, chromosomes & cancer 1996;15(3):191-4.
1996: Claude Preudhomme; N Philippe; E Macintyre; N Henic; Jean-Luc Lai; Jean-Pierre Jouet; Alain Cosson; Pierre Fenaux
Persistence of AML1/ETO fusion mRNA in t(8;21) acute myeloid leukemia (AML) in prolonged remission: is there a consensus?
Leukemia 1996;10(1):186-8.
1996: N Henic; Claude Preudhomme; M Noel; J Lai; Marc Wetterwald; M Simon; Pierre Fenaux
Frequency of molecular elimination of Ph1 clone in chronic myelogenous leukemia (CML) with interferon alpha.
Leukemia 1996;10(1):185-6.
1996: Eric Wattel; M Vanrumbeke; Mohamed Amine Abina; Nathalie Cambier; Claude Preudhomme; Hedi Haddada; Pierre Fenaux
Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies.
Leukemia 1996;10(1):171-4.
1995: Marc Zandecki; T Facon; Claude Preudhomme; M Vanrumbeke; A Vachee; Bruno Quesnel; Jean-Luc Lai; Alain Cosson; Pierre Fenaux
The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases.
Leukemia & lymphoma 1995;18(5-6):497-503.
1995: Bruno Quesnel; P Fenaux; N Philippe; J Fournier; J Bonneterre; Claude Preudhomme; J P Peyrat
Analysis of p16 gene deletion and point mutation in breast carcinoma.
British journal of cancer 1995;72(2):351-3.
1995: N Henic; Pierre Fenaux; Jean-Luc Lai; Claude Preudhomme
RNA for reverse PCR analysis can be obtained from bone marrow cells prepared for cytogenetic analysis and stored at -20 degrees C for several years.
Leukemia 1995;9(8):1409-11.
1995: Claude Preudhomme; Pascale Lepelley; V Lovi; Marc Zandecki; Alain Cosson; P Fenaux
T-cell acute lymphoblastic leukemia occurring in the course of B cell chronic lymphocytic leukemia: a case report.
Leukemia & lymphoma 1995;18(3-4):361-4.
1995: Claude Preudhomme; E Wattel; Jean-Luc Lai; N Henic; L Meyer; M P Noel; Alain Cosson; Jean-Pierre Jouet; Pierre Fenaux
Good predictive value of combined cytogenetic and molecular follow up in chronic myelogenous leukemia after non T-cell depleted allogeneic bone marrow transplantation: a report on 38 consecutive cases.
Leukemia & lymphoma 1995;18(3-4):265-71.
1995: Valérie Soenen; Pierre Fenaux; M Flactif; Pascale Lepelley; Jean-Luc Lai; Alain Cosson; Claude Preudhomme
Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes.
British journal of haematology 1995;90(3):701-6.
1995: Pascale Lepelley; Valérie Soenen; Claude Preudhomme; A Merlat; Alain Cosson; Pierre Fenaux
bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis.
Leukemia 1995;9(4):726-30.
1995: Claude Preudhomme; I Dervite; Eric Wattel; M Vanrumbeke; M Flactif; Jean-Luc Lai; B Hecquet; M C Coppin; Brigitte Nelken; B Gosselin
Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):812-20.
1995: Jean-Luc Lai; Claude Preudhomme; Marc Zandecki; M Flactif; M Vanrumbeke; Pascale Lepelley; Eric Wattel; Pierre Fenaux
Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Leukemia 1995;9(3):370-81.
1995: Bruno Quesnel; Claude Preudhomme; N Philippe; M Vanrumbeke; I Dervite; Jean-Luc Lai; Francis Bauters; Eric Wattel; P Fenaux
p16 gene homozygous deletions in acute lymphoblastic leukemia.
Blood 1995;85(3):657-63.
1995: H Bisiau; Agnès Daudignon; F Le Baron; J P Pollet; Claude Preudhomme; Patrick Duthilleul; C Bastard
Transformation of follicular lymphoma with both t(14;18) and t(8;22).
Nouvelle revue française d'hématologie 1995;37(4):241-4.
1994: Claude Preudhomme; M Vanrumbeke; Jean-Luc Lai; Pascale Lepelley; Eric Wattel; P Fenaux
Inactivation of the p53 gene in leukemias and myelodysplastic syndrome (MDS) with 17p monosomy.
Leukemia 1994;8(12):2241-2.
1994: Eric Wattel; Claude Preudhomme; B Hecquet; M Vanrumbeke; Bruno Quesnel; I Dervite; P Morel; P Fenaux
p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies.
Blood 1994;84(9):3148-57.
1994: N Henic; Claude Preudhomme; M Vanrumbeke; Pierre Fenaux
Absence of BCR-ABL rearrangement (with m-bcr breakpoint) in chronic myelomonocytic leukemia.
Leukemia 1994;8(10):1795-6.
1994: Bruno Quesnel; Claude Preudhomme; D Oscier; Pascale Lepelley; M Collyn-d'Hooghe; T Facon; Marc Zandecki; Pierre Fenaux
Over-expression of the MDM2 gene is found in some cases of haematological malignancies.
British journal of haematology 1994;88(2):415-8.
1994: Claude Preudhomme; R Lubin; Pascale Lepelley; M Vanrumbeke; P Fenaux
Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.
Leukemia 1994;8(9):1589-91.
1994: Pascale Lepelley; Claude Preudhomme; M Vanrumbeke; Bruno Quesnel; Alain Cosson; Pierre Fenaux
Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Leukemia 1994;8(8):1342-9.
1994: Marc Zandecki; Thierry Facon; Claude Preudhomme; F Canis; V Izydorczyk; V Lovi; M Hammad; Francis Bauters; Alain Cosson
Significance of circulating plasma cells in multiple myeloma.
Leukemia & lymphoma 1994;14(5-6):491-6.
1994: M Flactif; Jean-Luc Lai; Claude Preudhomme; Pierre Fenaux
Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes.
Leukemia 1994;8(6):1012-8.
1994: Pascale Lepelley; Valérie Soenen; Claude Preudhomme; Jean-Luc Lai; Alain Cosson; Pierre Fenaux
Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes.
Leukemia 1994;8(6):998-1004.
1994: Bruno Quesnel; Claude Preudhomme; M Vanrumbeke; A Vachee; Jean-Luc Lai; Pierre Fenaux
Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
Leukemia 1994;8(5):878-80.
1994: Claude Preudhomme; A Vachee; F Morschauser; N Henic; Alain Cosson; Pierre Fenaux
Immunoglobulin and T-cell receptor delta gene rearrangements are rarely found in myelodysplastic syndromes in chronic phase.
Leukemia research 1994;18(5):365-71.
1994: Claude Preudhomme; A Vachee; Pascale Lepelley; M Vanrumbeke; Marc Zandecki; Bruno Quesnel; Alain Cosson; Pierre Fenaux
Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes.
British journal of haematology 1994;87(1):61-7.
1994: Bruno Quesnel; Claude Preudhomme; J Fournier; P Fenaux; J P Peyrat
MDM2 gene amplification in human breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):982-4.
1993: Eric Wattel; Jean-Luc Laï; Mohamed Hebbar; Claude Preudhomme; D Grahek; P Morel; Francis Bauters; Pierre Fenaux
De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?
Leukemia research 1993;17(11):921-6.
1993: Claude Preudhomme; Pascale Lepelley; A Vachee; Valérie Soenen; Bruno Quesnel; Alain Cosson; Pierre Fenaux
Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.
Leukemia 1993;7(11):1888-90.
1993: P Morel; Mohamed Hebbar; Jean-Luc Lai; A Duhamel; Claude Preudhomme; Eric Wattel; Francis Bauters; Pierre Fenaux
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Leukemia 1993;7(9):1315-23.
1993: Claude Preudhomme; Bruno Quesnel; A Vachee; Pascale Lepelley; M Collyn-D'Hooghe; Eric Wattel; Pierre Fenaux
Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes.
Leukemia 1993;7(8):1291-3.
1993: T Facon; Jean-Luc Lai; E Nataf; Claude Preudhomme; Marc Zandecki; M Hammad; Eric Wattel; Jean-Pierre Jouet; Francis Bauters
Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients.
British journal of haematology 1993;84(4):743-5.
1993: Claude Preudhomme; A Vachee; Bruno Quesnel; Eric Wattel; Alain Cosson; Pierre Fenaux
Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
Leukemia 1993;7(7):1071.
1993: Claude Preudhomme; Pierre Fenaux; J L Lal; Pascale Lepelley; C Sartiaux; M Collyn-d'Hooghe; Marc Zandecki; Alain Cosson; J P Jouet; Jean-Pierre Kerckaert
Philadelphia negative, BCR-ABL positive adult acute lymphoblastic leukemia (ALL) in 2 of 39 patients with combined cytogenetic and molecular analysis.
Leukemia 1993;7(7):1054-7.
1993: Pascale Lepelley; Claude Preudhomme; C Sartiaux; C Ghevaert; Jean-Luc Lai; T Iaru; Pierre Fenaux; Alain Cosson
Immunological detection of myeloperoxidase in poorly differentiated acute leukemia.
European journal of haematology 1993;50(3):155-9.
1992: Claude Preudhomme; Jean-Luc Lai; I Plantier; Jean-Loup Demory; Marc Zandecki; Pierre Fenaux
Cytogenetic and molecular remission in a case of acute myeloid leukaemia(AML) with inversion of chromosome 16 (Inv(16)) and Philadelphia chromosome (Ph).
British journal of haematology 1992;82(3):623-6.
1992: Pierre Fenaux; Claude Preudhomme; Mohamed Hebbar
The role of intensive chemotherapy in myelodysplastic syndromes.
Leukemia & lymphoma 1992;8(1-2):43-9.
1992: Claude Preudhomme; T Facon; Marc Zandecki; M Vanrumbeke; Jean-Luc Laï; E Nataf; M H Loucheux-Lefebvre; Jean-Pierre Kerckaert; P Fenaux
Rare occurrence of P53 gene mutations in multiple myeloma.
British journal of haematology 1992;81(3):440-3.
1992: Pierre Fenaux; Claude Preudhomme; Jean-Luc Laï; I Quiquandon; P Jonveaux; M Vanrumbeke; C Sartiaux; P Morel; M H Loucheux-Lefebvre; Francis Bauters
Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis.
Leukemia 1992;6(4):246-50.
1992: Pierre Fenaux; Claude Preudhomme; I Quiquandon; P Jonveaux; Jean-Luc Laï; M Vanrumbeke; M H Loucheux-Lefebvre; Francis Bauters; Roland Berger; Jean-Pierre Kerckaert
Mutations of the P53 gene in acute myeloid leukaemia.
British journal of haematology 1992;80(2):178-83.
1992: Pierre Fenaux; P Jonveaux; I Quiquandon; Claude Preudhomme; Jean-Luc Lai; M Vanrumbeke; M H Loucheux-Lefebvre; Francis Bauters; Roland Berger; Jean-Pierre Kerckaert
Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases.
Leukemia 1992;6(1):42-6.
1990: M H Estienne; Pierre Fenaux; Claude Preudhomme; Jean-Luc Lai; Marc Zandecki; Pascale Lepelley; Alain Cosson
Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients.
Clinical and laboratory haematology 1990;12(1):57-65.